Please login to the form below

Not currently logged in
Email:
Password:

hepatitis C

This page shows the latest hepatitis C news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Biktarvy gets European approval, setting up battle with GSK

Gilead’s Biktarvy gets European approval, setting up battle with GSK

The drug could offset Gilead's disappointing hep C franchise. Gilead has gained European approval for its new HIV combination therapy Biktarvy, hot on the heels of GSK's rival Juluca. ... Gilead is relying on its HIV franchise to maintain its growth, as

Latest news

More from news
Approximately 104 fully matching, plus 270 partially matching documents found.

Latest Intelligence

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Meanwhile, the pharma industry is hitting new heights in drug innovation, including cures for diseases such as hepatitis C, haemophilia and huge progress in cancer and cell and gene therapy - but

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    on hepatitis C treatments and the recent introduction of the Budget Impact Test.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

More from intelligence
Approximately 3 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    BPH. Cardiovascular. Consumer health and nutrition. Contraception. Dermatology. Diabetes. GORD. Hepatitis C.

  • Access and elimination: the future of DAAs in hepatitis C

    Access and elimination: the future of DAAs in hepatitis C. Published in Pharmaphorum January 2017. ... The arrival of interferon-free, orally administered direct-acting antivirals (DAAs) in 2014 was a leap forward for the treatment of hepatitis C (HCV),

  • Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

    Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America. ... If left untreated, hepatitis C leads to chronic health problems putting a huge strain on national healthcare resources.

  • 90TEN nominated for five Communiqué Awards

    The agency’ s Hepatitis C medical education programme for AbbVie, ‘ Revealing a New Face of Cure’, has been shortlisted for Excellence in Communications via a Live Event or Stand Alone Activity.

  • Atlantis Healthcare

    haemophilia. hepatitis C. incontinence. multiple sclerosis. osteoporosis . rheumatoid arthritis. Additionally, Atlantis has delivered many programmes to support rare diseases, health screening and blood donor management.

More from PMHub
Approximately 4 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics